found that a high density of proinflammatory CD64+ macrophages in close proximity with CD8 in the tumor microenvironment correlated with increased median overall survival in patients with multiple cancer types undergoing PD-1 therapy (69). This evidence concerns the gene PDCD1 and neoplasm.